Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Giselle de Faria Romero"'
Autor:
Giselle de Faria Romero Soldi, Isadora Coutinho Ribeiro, Cintia Mayumi Ahagon, Luana Portes Ozório Coelho, Gabriela Bastos Cabral, Giselle Ibette Silva López Lopes, João Leandro de Paula Ferreira, Luís Fernando de Macedo Brígido, Salvage Therapy Working Group
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223210 (2019)
BACKGROUND:Protease inhibitors (PI) are especially important in salvage therapy. Previous treatment failure with a PI containing regimen may elicit resistance mutations, reducing PI susceptibility and limiting treatment options. The aim of this study
Externí odkaz:
https://doaj.org/article/6a65b7e9f64d419c9f35d3897a367361
Autor:
Soldi, Giselle de Faria Romero1, Ribeiro, Isadora Coutinho1, Ahagon, Cintia Mayumi1, Coelho, Luana Portes Ozório1, Cabral, Gabriela Bastos1, Lopes, Giselle Ibette Silva López1, Ferreira, João Leandro de Paula1, Brígido, Luís Fernando de Macedo1 lubrigido@gmail.com, null, null1
Publikováno v:
PLoS ONE. 10/1/2019, Vol. 14 Issue 10, p1-15. 15p.
Autor:
Giselle de Faria Romero Soldi, Luís Fernando de Macedo Brígido, Mihr workgroup, Roberta Schiavon Nogueira, Leda Fátima Jamal, Mônica Jacques de Moraes, Luana Portes Ozório Coelho, Elaine Monteiro Matsuda, Aline Carralas Leão, Mariza Vono Tancredi, José Valdez Madruga
Publikováno v:
Archives of Virology. 164:699-706
HIV-1 transmitted drug resistance (TDR) mutations may reduce the efficacy of antiretroviral therapy (ART), but pre-treatment testing to determine the virus genotype can improve the efficacy of ART. Unfortunately, issues related to cost and logistics
Autor:
Elaine Monteiro Matsuda, Luana Portes Ozório Coelho, Giselle de Faria Romero, Monica Jacques de Moraes, Giselle Ibete Silva Lopez-Lopes, Karen Morejon, Alexandre Ely Campeas, Gabriela Bastos Cabral, Luís Fernando de Macedo Brígido, null Salvage Therapy Working Group
Publikováno v:
AIDS research and human retroviruses. 34(2)
Universal antiretroviral treatment with sustained viral suppression benefits patients and reduces HIV transmission. Effectiveness of therapy may be limited by antiretroviral drug resistance. Information on the resistance profile at treatment failure